Prothena Corp Public (PRTA) Net Margin Growth (3y) (2015 - 2026)

Prothena Corp Public (PRTA) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Prothena Corp Public 458.13 Mn 128.67 Mn - 222,523.00

Historic Data

Download Data
DateValue
Mar 31, 2026 222,523.00
Dec 31, 2025 -10.26 Mn
Sep 30, 2025 150,176.00
Jun 30, 2025 30,032.00
Mar 31, 2025 101,891.00
Dec 31, 2024 9,673.00
Sep 30, 2024 -616,468.00
Jun 30, 2024 470.00
Mar 31, 2024 -12.15 Mn
Dec 31, 2023 -1.28 Mn
Sep 30, 2023 1.95 Mn
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 843,225.00
Sep 30, 2022 647,318.00
Jun 30, 2022 632,133.00
Mar 31, 2022 807,030.00
Dec 31, 2021 875,002.00
Sep 30, 2021 970,948.00
Jun 30, 2021 2.15 Mn